ReP USP - Resultado da busca

Artigo de periodico
Cell death induced by NLRP3–palmitate axis impairs pulmonary damage tolerance and aggravates immunopathology during obesity-tuberculosis comorbidity (2023)
Albornoz, Sandra Patrícia Palma ; Silva, Thais Fernanda de Campo Fraga da ; Carvalho, Renan Villanova Homem de ; Rodrigues, Tamara Silva; Gembre, Ana Flávia; Oliveira, Rômulo Silva de; Souza, Fernanda Mesquita de; Corrêa, Giseli Furlan ; Ramalho, Leandra Naira Zambelli ; Sartori, Daniela Carlos ; Câmara, Niels Olsen Saraiva ; Zamboni, Dario Simões ; Takahashi, Viviani Nardini ; Sorgi, Carlos Artério ; Faccioli, Lucia Helena ; Medeiros, Alexandra Ivo de ; Costa, Diego Luís ; Bonato, Vânia Luiza Deperon
Source: Journal of Pathology. Unidades: FMRP, ICB, FCFRP, FFCLRP, ESALQ
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBORNOZ, Sandra Patrícia Palma et al. Cell death induced by NLRP3–palmitate axis impairs pulmonary damage tolerance and aggravates immunopathology during obesity-tuberculosis comorbidity. Journal of Pathology, v. 259, p. 291-303, 2023Tradução . . Disponível em: https://doi.org/10.1002/path.6041. Acesso em: 16 nov. 2024.
APA
Albornoz, S. P. P., Silva, T. F. de C. F. da, Carvalho, R. V. H. de, Rodrigues, T. S., Gembre, A. F., Oliveira, R. S. de, et al. (2023). Cell death induced by NLRP3–palmitate axis impairs pulmonary damage tolerance and aggravates immunopathology during obesity-tuberculosis comorbidity. Journal of Pathology, 259, 291-303. doi:10.1002/path.6041
NLM
Albornoz SPP, Silva TF de CF da, Carvalho RVH de, Rodrigues TS, Gembre AF, Oliveira RS de, Souza FM de, Corrêa GF, Ramalho LNZ, Sartori DC, Câmara NOS, Zamboni DS, Takahashi VN, Sorgi CA, Faccioli LH, Medeiros AI de, Costa DL, Bonato VLD. Cell death induced by NLRP3–palmitate axis impairs pulmonary damage tolerance and aggravates immunopathology during obesity-tuberculosis comorbidity [Internet]. Journal of Pathology. 2023 ; 259 291-303.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/path.6041
Vancouver
Albornoz SPP, Silva TF de CF da, Carvalho RVH de, Rodrigues TS, Gembre AF, Oliveira RS de, Souza FM de, Corrêa GF, Ramalho LNZ, Sartori DC, Câmara NOS, Zamboni DS, Takahashi VN, Sorgi CA, Faccioli LH, Medeiros AI de, Costa DL, Bonato VLD. Cell death induced by NLRP3–palmitate axis impairs pulmonary damage tolerance and aggravates immunopathology during obesity-tuberculosis comorbidity [Internet]. Journal of Pathology. 2023 ; 259 291-303.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/path.6041
Artigo de periodico
BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia (2023)
Brumatti, Gabriela ; Kaloni, Deeksha ; Castro, Fabíola Attié de ; Amarante-Mendes, João Gustavo Pessini
Source: Biochemical Journal. Unidades: FCFRP, ICB
Subjects: IMUNOLOGIA, LEUCEMIA MIELOIDE AGUDA, NEOPLASIAS POR TIPO HISTOLÓGICO, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRUMATTI, Gabriela et al. BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia. Biochemical Journal, v. 480, p. 161–176, 2023Tradução . . Disponível em: https://doi.org/10.1042/BCJ20210608. Acesso em: 16 nov. 2024.
APA
Brumatti, G., Kaloni, D., Castro, F. A. de, & Amarante-Mendes, J. G. P. (2023). BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia. Biochemical Journal, 480, 161–176. doi:10.1042/BCJ20210608
NLM
Brumatti G, Kaloni D, Castro FA de, Amarante-Mendes JGP. BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia [Internet]. Biochemical Journal. 2023 ; 480 161–176.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1042/BCJ20210608
Vancouver
Brumatti G, Kaloni D, Castro FA de, Amarante-Mendes JGP. BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia [Internet]. Biochemical Journal. 2023 ; 480 161–176.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1042/BCJ20210608
Artigo de periodico
Decitabine promotes modulation in phenotype and function of monocytes and macrophages that drive immune response regulation (2021)
Zambuzi, Fabiana Albani ; Silva, Priscilla Mariane Cardoso; Castro, Ricardo Cardoso ; Fontanari, Caroline ; Emery, Flavio da Silva ; Frantz, Fabiani Gai
Source: Cells. Unidades: FCFRP, FMRP
Subjects: FAGOCITOSE, MONÓCITOS, MACRÓFAGOS, ADJUVANTES IMUNOLÓGICOS, SISTEMA IMUNE, IMUNOLOGIA, FENÓTIPOS, DOENÇAS INFECCIOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMBUZI, Fabiana Albani et al. Decitabine promotes modulation in phenotype and function of monocytes and macrophages that drive immune response regulation. Cells, v. 10, n. 4, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.3390/cells10040868. Acesso em: 16 nov. 2024.
APA
Zambuzi, F. A., Silva, P. M. C., Castro, R. C., Fontanari, C., Emery, F. da S., & Frantz, F. G. (2021). Decitabine promotes modulation in phenotype and function of monocytes and macrophages that drive immune response regulation. Cells, 10( 4), 1-16. doi:10.3390/cells10040868
NLM
Zambuzi FA, Silva PMC, Castro RC, Fontanari C, Emery F da S, Frantz FG. Decitabine promotes modulation in phenotype and function of monocytes and macrophages that drive immune response regulation [Internet]. Cells. 2021 ; 10( 4): 1-16.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/cells10040868
Vancouver
Zambuzi FA, Silva PMC, Castro RC, Fontanari C, Emery F da S, Frantz FG. Decitabine promotes modulation in phenotype and function of monocytes and macrophages that drive immune response regulation [Internet]. Cells. 2021 ; 10( 4): 1-16.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/cells10040868
Artigo de periodico
AeMOPE-1, a novel salivary peptide from Aedes aegypti, selectively modulates activation of murine macrophages and ameliorates experimental colitis (2021)
Lara, Priscila Guirão; Esteves, Eliane Virgínia da Silva ; Campos, Helioswilton Sales de; Assis, Josiane Betim de ; Henrique, Maressa de Oliveira ; Barros, Michele Silva de; Santos Neto, Leila; Silva Junior, Pedro I. ; Martins, Joilson de Oliveira ; Cardoso, Cristina Ribeiro de Barros; Ribeiro, José M. C.; Nunes, Anderson de Sá
Source: Frontiers in Immunology. Unidades: ICB, FCF, FCFRP
Subjects: IMUNOLOGIA, PEPTÍDEOS, AEDES, GLÂNDULAS SALIVARES, MACRÓFAGOS, COLITE, ADJUVANTES IMUNOLÓGICOS, SALIVA, ÓXIDO NÍTRICO, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LARA, Priscila Guirão et al. AeMOPE-1, a novel salivary peptide from Aedes aegypti, selectively modulates activation of murine macrophages and ameliorates experimental colitis. Frontiers in Immunology, v. 12, p. 1-15, 2021Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2021.681671. Acesso em: 16 nov. 2024.
APA
Lara, P. G., Esteves, E. V. da S., Campos, H. S. de, Assis, J. B. de, Henrique, M. de O., Barros, M. S. de, et al. (2021). AeMOPE-1, a novel salivary peptide from Aedes aegypti, selectively modulates activation of murine macrophages and ameliorates experimental colitis. Frontiers in Immunology, 12, 1-15. doi:10.3389/fimmu.2021.681671
NLM
Lara PG, Esteves EV da S, Campos HS de, Assis JB de, Henrique M de O, Barros MS de, Santos Neto L, Silva Junior PI, Martins J de O, Cardoso CR de B, Ribeiro JMC, Nunes A de S. AeMOPE-1, a novel salivary peptide from Aedes aegypti, selectively modulates activation of murine macrophages and ameliorates experimental colitis [Internet]. Frontiers in Immunology. 2021 ; 12 1-15.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2021.681671
Vancouver
Lara PG, Esteves EV da S, Campos HS de, Assis JB de, Henrique M de O, Barros MS de, Santos Neto L, Silva Junior PI, Martins J de O, Cardoso CR de B, Ribeiro JMC, Nunes A de S. AeMOPE-1, a novel salivary peptide from Aedes aegypti, selectively modulates activation of murine macrophages and ameliorates experimental colitis [Internet]. Frontiers in Immunology. 2021 ; 12 1-15.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2021.681671
Artigo de periodico
NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8 + T cell responses (2021)
Souza, Camila Oliveira de; Ketelut-Carneiro, Natália; Milanezi, Cristiane Maria; Faccioli, Lucia Helena ; Gardinassi, Luiz G; Silva, João Santana da
Source: iScience. Unidades: EERP, FCFRP, FMRP
Subjects: IMUNOLOGIA, MICOLOGIA, ANTIFÚNGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Camila Oliveira de et al. NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8 + T cell responses. iScience, v. 24, n. 6, p. 1-19, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.isci.2021.102548. Acesso em: 16 nov. 2024.
APA
Souza, C. O. de, Ketelut-Carneiro, N., Milanezi, C. M., Faccioli, L. H., Gardinassi, L. G., & Silva, J. S. da. (2021). NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8 + T cell responses. iScience, 24( 6), 1-19. doi:10.1016/j.isci.2021.102548
NLM
Souza CO de, Ketelut-Carneiro N, Milanezi CM, Faccioli LH, Gardinassi LG, Silva JS da. NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8 + T cell responses [Internet]. iScience. 2021 ; 24( 6): 1-19.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.isci.2021.102548
Vancouver
Souza CO de, Ketelut-Carneiro N, Milanezi CM, Faccioli LH, Gardinassi LG, Silva JS da. NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8 + T cell responses [Internet]. iScience. 2021 ; 24( 6): 1-19.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.isci.2021.102548
Artigo de periodico
Guidelines for the use and interpretation of assays for monitoring autophagy (2021)
Klionsky, Daniel J ; Baptista, Maurício da Silva ; Martins, Joilson de Oliveira ; Brum, Patrícia Chakur ; Ferreira, Julio Cesar Batista ; Palmisano, Giuseppe ; Câmara, Niels Olsen Saraiva ; Leopoldino, Andréia Machado ; Araújo, Thaís Fenz
Source: Autophagy. Unidades: IQ, FCF, EEFE, ICB, FCFRP
Subjects: NEOPLASIAS, LISOSSOMOS, CÉLULAS, BIOLOGIA CELULAR, ANATOMIA, PARASITOLOGIA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KLIONSKY, Daniel J et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, v. 17, n. 1, p. 1-382, 2021Tradução . . Disponível em: https://www.tandfonline.com/doi/full/10.1080/15548627.2020.1797280. Acesso em: 16 nov. 2024.
APA
Klionsky, D. J., Baptista, M. da S., Martins, J. de O., Brum, P. C., Ferreira, J. C. B., Palmisano, G., et al. (2021). Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy, 17( 1), 1-382. Recuperado de https://www.tandfonline.com/doi/full/10.1080/15548627.2020.1797280
NLM
Klionsky DJ, Baptista M da S, Martins J de O, Brum PC, Ferreira JCB, Palmisano G, Câmara NOS, Leopoldino AM, Araújo TF. Guidelines for the use and interpretation of assays for monitoring autophagy [Internet]. Autophagy. 2021 ; 17( 1): 1-382.[citado 2024 nov. 16 ] Available from: https://www.tandfonline.com/doi/full/10.1080/15548627.2020.1797280
Vancouver
Klionsky DJ, Baptista M da S, Martins J de O, Brum PC, Ferreira JCB, Palmisano G, Câmara NOS, Leopoldino AM, Araújo TF. Guidelines for the use and interpretation of assays for monitoring autophagy [Internet]. Autophagy. 2021 ; 17( 1): 1-382.[citado 2024 nov. 16 ] Available from: https://www.tandfonline.com/doi/full/10.1080/15548627.2020.1797280
Artigo de periodico
Publisher Correction: Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition (2020)
Carvalho, Renan Villanova Homem de; Lima Júnior, Djalma Souza; Silva, Marcus Vinícius Gomes da; Dilucca, Marisa; Rodrigues, Tamara Silva; Horta, Catarina Veltrini; Silva, Alexandre Luiz Neves; Silva, Patrick Fernandes da; Frantz, Fabiani Gai ; Lorenzon, Lucas Bigolin; Souza, Marcos Michel de; Almeida, Fausto Bruno dos Reis ; Cantanhêde, Lilian Motta; Ferreira, Ricardo de Godoi Mattos; Cruz, Angela Kaysel ; Zamboni, Dario Simões
Source: Nature Communications. Unidades: FCFRP, FMRP
Subjects: IMUNOLOGIA, VÍRUS DE RNA, LEISHMANIA, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Renan Villanova Homem de et al. Publisher Correction: Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition. Nature Communications, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.1038/s41467-019-13356-2. Acesso em: 16 nov. 2024.
APA
Carvalho, R. V. H. de, Lima Júnior, D. S., Silva, M. V. G. da, Dilucca, M., Rodrigues, T. S., Horta, C. V., et al. (2020). Publisher Correction: Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition. Nature Communications, 11. doi:10.1038/s41467-019-13356-2
NLM
Carvalho RVH de, Lima Júnior DS, Silva MVG da, Dilucca M, Rodrigues TS, Horta CV, Silva ALN, Silva PF da, Frantz FG, Lorenzon LB, Souza MM de, Almeida FB dos R, Cantanhêde LM, Ferreira R de GM, Cruz AK, Zamboni DS. Publisher Correction: Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition [Internet]. Nature Communications. 2020 ; 11[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41467-019-13356-2
Vancouver
Carvalho RVH de, Lima Júnior DS, Silva MVG da, Dilucca M, Rodrigues TS, Horta CV, Silva ALN, Silva PF da, Frantz FG, Lorenzon LB, Souza MM de, Almeida FB dos R, Cantanhêde LM, Ferreira R de GM, Cruz AK, Zamboni DS. Publisher Correction: Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition [Internet]. Nature Communications. 2020 ; 11[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41467-019-13356-2
Artigo de periodico
Multifaceted antibodies development against synthetic α-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnostic (2020)
Léo, Thais Canassa De ; Campo, Vanessa Leiria; Rodrigues, Lilian Cataldi ; Marchiori, Marcelo Fiori; Fuzo, Carlos Alessandro; Brigido, Marcelo Macedo; Sandomenico, Annamaria; Ruvo, Menotti; Maranhão, Andrea Queiroz; Dias-Baruffi, Marcelo
Source: Glycoconjugate Journal. Unidade: FCFRP
Subjects: ANTICORPOS MONOCLONAIS, IMUNOLOGIA, GLICOPROTEÍNAS, SÍNTESE QUÍMICA, DISTROFIA MUSCULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LÉO, Thais Canassa De et al. Multifaceted antibodies development against synthetic α-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnostic. Glycoconjugate Journal, v. 37, n. 1, p. 77-93, 2020Tradução . . Disponível em: https://doi.org/10.1007/s10719-019-09893-z. Acesso em: 16 nov. 2024.
APA
Léo, T. C. D., Campo, V. L., Rodrigues, L. C., Marchiori, M. F., Fuzo, C. A., Brigido, M. M., et al. (2020). Multifaceted antibodies development against synthetic α-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnostic. Glycoconjugate Journal, 37( 1), 77-93. doi:10.1007/s10719-019-09893-z
NLM
Léo TCD, Campo VL, Rodrigues LC, Marchiori MF, Fuzo CA, Brigido MM, Sandomenico A, Ruvo M, Maranhão AQ, Dias-Baruffi M. Multifaceted antibodies development against synthetic α-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnostic [Internet]. Glycoconjugate Journal. 2020 ; 37( 1): 77-93.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10719-019-09893-z
Vancouver
Léo TCD, Campo VL, Rodrigues LC, Marchiori MF, Fuzo CA, Brigido MM, Sandomenico A, Ruvo M, Maranhão AQ, Dias-Baruffi M. Multifaceted antibodies development against synthetic α-dystroglycan mucin glycopeptide as promising tools for dystroglycanopathies diagnostic [Internet]. Glycoconjugate Journal. 2020 ; 37( 1): 77-93.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s10719-019-09893-z
Artigo de periodico
Neutrophils and COVID-19:: what is going on? (2020)
Andrade, Micássio Fernandes de ; Marzocchi-Machado, Cleni Mara
Source: Critical Reviews in Immunology. Unidade: FCFRP
Subjects: COVID-19, METABOLISMO, IMUNOLOGIA, NEUTRÓFILOS, FISIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Micássio Fernandes de e MARZOCCHI-MACHADO, Cleni Mara. Neutrophils and COVID-19:: what is going on?. Critical Reviews in Immunology, v. 40, n. 6, p. 527-536, 2020Tradução . . Disponível em: https://doi.org/10.1615/CritRevImmunol.2020035900. Acesso em: 16 nov. 2024.
APA
Andrade, M. F. de, & Marzocchi-Machado, C. M. (2020). Neutrophils and COVID-19:: what is going on? Critical Reviews in Immunology, 40( 6), 527-536. doi:10.1615/CritRevImmunol.2020035900
NLM
Andrade MF de, Marzocchi-Machado CM. Neutrophils and COVID-19:: what is going on? [Internet]. Critical Reviews in Immunology. 2020 ; 40( 6): 527-536.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1615/CritRevImmunol.2020035900
Vancouver
Andrade MF de, Marzocchi-Machado CM. Neutrophils and COVID-19:: what is going on? [Internet]. Critical Reviews in Immunology. 2020 ; 40( 6): 527-536.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1615/CritRevImmunol.2020035900
Artigo de periodico-carta/editorial
CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] (2020)
Arruda, Lucas Coelho Marliére; Clave, Emmanuel; Douay, Corinne; Lima Júnior, João Rodrigues; Slavov, Svetoslav Nanev; Farias, Kelen Cristina Ribeiro Malmegrim de ; Alberdi, Antônio José; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine
Source: Rheumatology. Unidades: FMRP, FCFRP
Subjects: CÉLULAS CLONAIS, IMUNOLOGIA, CITOMEGALOVIRUS, TRANSPLANTES, CÉLULAS-TRONCO, RECEPTORES, ANTÍGENOS, VIROLOGIA, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARRUDA, Lucas Coelho Marliére et al. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]. Rheumatology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/rheumatology/keaa001. Acesso em: 16 nov. 2024. , 2020
APA
Arruda, L. C. M., Clave, E., Douay, C., Lima Júnior, J. R., Slavov, S. N., Farias, K. C. R. M. de, et al. (2020). CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta]. Rheumatology. Oxford: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/rheumatology/keaa001
NLM
Arruda LCM, Clave E, Douay C, Lima Júnior JR, Slavov SN, Farias KCRM de, Alberdi AJ, Rodrigues MC de O, Toubert A. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] [Internet]. Rheumatology. 2020 ; 59( 9): e38-e40.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1093/rheumatology/keaa001
Vancouver
Arruda LCM, Clave E, Douay C, Lima Júnior JR, Slavov SN, Farias KCRM de, Alberdi AJ, Rodrigues MC de O, Toubert A. CMV-specific clones may lead to reduced TCR diversity and relapse in systemic sclerosis patients treated with AHSCT [Carta] [Internet]. Rheumatology. 2020 ; 59( 9): e38-e40.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1093/rheumatology/keaa001
Artigo de periodico
Immunosenescence in chronic HIV infected patients impairs essential functions of their natural killer cells (2020)
Soares, Luana Silva; Espíndola, Milena Sobral; Zambuzi, Fabiana Albani; Lima, Leonardo Judson Galvão de; Cacemiro, Maira da Costa ; Soares, Murilo Racy ; Santana, Bárbara Amélia Aparecida; Calado, Rodrigo Tocantins ; Bollela, Valdes Roberto; Frantz, Fabiani Gai
Source: International Immunopharmacology. Unidades: FMRP, FCFRP
Subjects: DOENÇA AGUDA, DOENÇA CRÔNICA, CITOCINAS, METILAÇÃO DE DNA, INFECÇÕES POR HIV, IMUNOLOGIA, ESPÉCIES REATIVAS DE OXIGÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Luana Silva et al. Immunosenescence in chronic HIV infected patients impairs essential functions of their natural killer cells. International Immunopharmacology, v. 84, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.intimp.2020.106568. Acesso em: 16 nov. 2024.
APA
Soares, L. S., Espíndola, M. S., Zambuzi, F. A., Lima, L. J. G. de, Cacemiro, M. da C., Soares, M. R., et al. (2020). Immunosenescence in chronic HIV infected patients impairs essential functions of their natural killer cells. International Immunopharmacology, 84. doi:10.1016/j.intimp.2020.106568
NLM
Soares LS, Espíndola MS, Zambuzi FA, Lima LJG de, Cacemiro M da C, Soares MR, Santana BAA, Calado RT, Bollela VR, Frantz FG. Immunosenescence in chronic HIV infected patients impairs essential functions of their natural killer cells [Internet]. International Immunopharmacology. 2020 ; 84[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.intimp.2020.106568
Vancouver
Soares LS, Espíndola MS, Zambuzi FA, Lima LJG de, Cacemiro M da C, Soares MR, Santana BAA, Calado RT, Bollela VR, Frantz FG. Immunosenescence in chronic HIV infected patients impairs essential functions of their natural killer cells [Internet]. International Immunopharmacology. 2020 ; 84[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.intimp.2020.106568
Parte de monografia/livro
CAR-T cells for cancer treatment: current design and next frontiers (2020)
Picanço-Castro, Virgínia; Swiech, Kamilla ; Farias, Kelen Cristina Ribeiro Malmegrim de ; Covas, Dimas Tadeu
Source: Chimeric Antigen Receptor T Cell: Development and Production. Unidades: FCFRP, FMRP
Subjects: IMUNOTERAPIA, NEOPLASIAS, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PICANÇO-CASTRO, Virgínia et al. CAR-T cells for cancer treatment: current design and next frontiers. Chimeric Antigen Receptor T Cell: Development and Production. Tradução . New York: Humana Press, 2020. . Disponível em: https://doi.org/10.1007/978-1-0716-0146-4_1. Acesso em: 16 nov. 2024.
APA
Picanço-Castro, V., Swiech, K., Farias, K. C. R. M. de, & Covas, D. T. (2020). CAR-T cells for cancer treatment: current design and next frontiers. In Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4_1
NLM
Picanço-Castro V, Swiech K, Farias KCRM de, Covas DT. CAR-T cells for cancer treatment: current design and next frontiers [Internet]. In: Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press; 2020. [citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4_1
Vancouver
Picanço-Castro V, Swiech K, Farias KCRM de, Covas DT. CAR-T cells for cancer treatment: current design and next frontiers [Internet]. In: Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press; 2020. [citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4_1
Tese (Livre Docência)
Monitoramento imunológico após transplante de células-tronco hematopoiéticas: identificação de biomarcadores de resposta ao tratamento (2019)
Farias, Kelen Cristina Ribeiro Malmegrim de
Unidade: FCFRP
Subjects: TRANSPLANTES, CÉLULAS-TRONCO, IMUNOLOGIA, DOENÇAS AUTOIMUNES, BIOMARCADORES, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de. Monitoramento imunológico após transplante de células-tronco hematopoiéticas: identificação de biomarcadores de resposta ao tratamento. 2019. Tese (Livre Docência) – Universidade de São Paulo, Ribeirão Preto, 2019. . Acesso em: 16 nov. 2024.
APA
Farias, K. C. R. M. de. (2019). Monitoramento imunológico após transplante de células-tronco hematopoiéticas: identificação de biomarcadores de resposta ao tratamento (Tese (Livre Docência). Universidade de São Paulo, Ribeirão Preto.
NLM
Farias KCRM de. Monitoramento imunológico após transplante de células-tronco hematopoiéticas: identificação de biomarcadores de resposta ao tratamento. 2019 ;[citado 2024 nov. 16 ]
Vancouver
Farias KCRM de. Monitoramento imunológico após transplante de células-tronco hematopoiéticas: identificação de biomarcadores de resposta ao tratamento. 2019 ;[citado 2024 nov. 16 ]
Artigo de periodico
Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition (2019)
Carvalho, Renan Villanova Homem de; Lima Júnior, Djalma Souza; Silva, Marcus Vinícius Gomes da; Dilucca, Marisa; Rodrigues, Tamara Silva; Horta, Catarina Veltrini; Silva, Alexandre Luiz Neves; Silva, Patrick Fernandes da; Frantz, Fabiani Gai ; Lorenzon, Lucas Bigolin; Souza, Marcos Michel de; Almeida, Fausto Bruno dos Reis ; Cantanhêde, Lilian Motta; Ferreira, Ricardo de Godoi Mattos; Cruz, Angela Kaysel ; Zamboni, Dario Simões
Source: Nature Communications. Unidades: FCFRP, FMRP
Subjects: IMUNOLOGIA, VÍRUS DE RNA, LEISHMANIA, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Renan Villanova Homem de et al. Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition. Nature Communications, v. 10, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41467-019-13356-2. Acesso em: 16 nov. 2024.
APA
Carvalho, R. V. H. de, Lima Júnior, D. S., Silva, M. V. G. da, Dilucca, M., Rodrigues, T. S., Horta, C. V., et al. (2019). Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition. Nature Communications, 10. doi:10.1038/s41467-019-13356-2
NLM
Carvalho RVH de, Lima Júnior DS, Silva MVG da, Dilucca M, Rodrigues TS, Horta CV, Silva ALN, Silva PF da, Frantz FG, Lorenzon LB, Souza MM de, Almeida FB dos R, Cantanhêde LM, Ferreira R de GM, Cruz AK, Zamboni DS. Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition [Internet]. Nature Communications. 2019 ; 10[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41467-019-13356-2
Vancouver
Carvalho RVH de, Lima Júnior DS, Silva MVG da, Dilucca M, Rodrigues TS, Horta CV, Silva ALN, Silva PF da, Frantz FG, Lorenzon LB, Souza MM de, Almeida FB dos R, Cantanhêde LM, Ferreira R de GM, Cruz AK, Zamboni DS. Leishmania RNA virus exacerbates Leishmaniasis by subverting innate immunity via TLR3-mediated NLRP3 inflammasome inhibition [Internet]. Nature Communications. 2019 ; 10[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41467-019-13356-2
Artigo de periodico
Amblyomma sculptum salivary PGE2 modulates the dendritic cell-Rickettsia rickettsii interactions in vitro and in vivo (2019)
Esteves, Eliane; Bizzarro, Bruna; Costa, Francisco Borges da; Ramírez-Hernández, Alejandro; Peti, Ana Paula Ferranti; Cataneo, Allan Henrique Depieri; Wowk, Pryscilla Fanini; Timóteo, Rodolfo Pessato; Labruna, Marcelo Bahia ; Silva Júnior, Pedro Ismael da; Silva, Célio Lopes; Faccioli, Lucia Helena; Fogaça, Andréa Cristina ; Sorgi, Carlos Arterio; Nunes, Anderson de Sá
Source: Frontiers in Immunology. Unidades: FMVZ, FMRP, FCFRP, ICB
Subjects: FEBRE MACULOSA, DOENÇAS TRANSMITIDAS POR CARRAPATOS, IXÓDIDAE, ADJUVANTES IMUNOLÓGICOS, IMUNOLOGIA, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ESTEVES, Eliane et al. Amblyomma sculptum salivary PGE2 modulates the dendritic cell-Rickettsia rickettsii interactions in vitro and in vivo. Frontiers in Immunology, v. 10, p. 1-15, 2019Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2019.00118. Acesso em: 16 nov. 2024.
APA
Esteves, E., Bizzarro, B., Costa, F. B. da, Ramírez-Hernández, A., Peti, A. P. F., Cataneo, A. H. D., et al. (2019). Amblyomma sculptum salivary PGE2 modulates the dendritic cell-Rickettsia rickettsii interactions in vitro and in vivo. Frontiers in Immunology, 10, 1-15. doi:10.3389/fimmu.2019.00118
NLM
Esteves E, Bizzarro B, Costa FB da, Ramírez-Hernández A, Peti APF, Cataneo AHD, Wowk PF, Timóteo RP, Labruna MB, Silva Júnior PI da, Silva CL, Faccioli LH, Fogaça AC, Sorgi CA, Nunes A de S. Amblyomma sculptum salivary PGE2 modulates the dendritic cell-Rickettsia rickettsii interactions in vitro and in vivo [Internet]. Frontiers in Immunology. 2019 ; 10 1-15.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2019.00118
Vancouver
Esteves E, Bizzarro B, Costa FB da, Ramírez-Hernández A, Peti APF, Cataneo AHD, Wowk PF, Timóteo RP, Labruna MB, Silva Júnior PI da, Silva CL, Faccioli LH, Fogaça AC, Sorgi CA, Nunes A de S. Amblyomma sculptum salivary PGE2 modulates the dendritic cell-Rickettsia rickettsii interactions in vitro and in vivo [Internet]. Frontiers in Immunology. 2019 ; 10 1-15.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2019.00118
Artigo de periodico
Participation of Leukotrienes in the immune modulation of oral tolerance (2017)
Oliveira, Sandra R. P; Nomizo, Auro; Frantz, Fabiani G; Faccioli, Lucia Helena; Matos, Ana Paula Keller de; Carrilho, Emanuel ; Afonso, Ana; Anibal, Fernanda de Freitas
Source: Frontiers in Microbiology. Unidades: FCFRP, IQSC
Assunto: IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Sandra R. P et al. Participation of Leukotrienes in the immune modulation of oral tolerance. Frontiers in Microbiology, v. 8, p. XX, 2017Tradução . . Disponível em: https://doi.org/10.3389/fmicb.2017.002.42. Acesso em: 16 nov. 2024.
APA
Oliveira, S. R. P., Nomizo, A., Frantz, F. G., Faccioli, L. H., Matos, A. P. K. de, Carrilho, E., et al. (2017). Participation of Leukotrienes in the immune modulation of oral tolerance. Frontiers in Microbiology, 8, XX. doi:10.3389/fmicb.2017.002.42
NLM
Oliveira SRP, Nomizo A, Frantz FG, Faccioli LH, Matos APK de, Carrilho E, Afonso A, Anibal F de F. Participation of Leukotrienes in the immune modulation of oral tolerance [Internet]. Frontiers in Microbiology. 2017 ; 8 XX.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fmicb.2017.002.42
Vancouver
Oliveira SRP, Nomizo A, Frantz FG, Faccioli LH, Matos APK de, Carrilho E, Afonso A, Anibal F de F. Participation of Leukotrienes in the immune modulation of oral tolerance [Internet]. Frontiers in Microbiology. 2017 ; 8 XX.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fmicb.2017.002.42
Artigo de periodico
Erythropoietin exacerbates inflammation and increases the mortality of histoplasma capsulatum-infected mice (2015)
Locachevic, Gisele Aparecida; Pereira, Priscilla Aparecida Tartari; Secatto, Adriana; Fontanari, Caroline; Galvão, Alyne Fávero; Prado, Morgana Kelly Borges; Zoccal, Karina Furlani; Petta, Tânia; Moraes, Luiz Alberto Beraldo de; Ramos, Simone Gusmão; Castro, Fabíola Attié de; Sorgi, Carlos Artério; Faccioli, Lucia Helena
Source: Mediators of Inflammation. Unidades: FCFRP, FFCLRP, FMRP
Subjects: ERITROPOIETINA, MACRÓFAGOS, HISTOPLASMA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOCACHEVIC, Gisele Aparecida et al. Erythropoietin exacerbates inflammation and increases the mortality of histoplasma capsulatum-infected mice. Mediators of Inflammation, v. 2015, 2015Tradução . . Disponível em: https://doi.org/10.1155/2015/786319. Acesso em: 16 nov. 2024.
APA
Locachevic, G. A., Pereira, P. A. T., Secatto, A., Fontanari, C., Galvão, A. F., Prado, M. K. B., et al. (2015). Erythropoietin exacerbates inflammation and increases the mortality of histoplasma capsulatum-infected mice. Mediators of Inflammation, 2015. doi:10.1155/2015/786319
NLM
Locachevic GA, Pereira PAT, Secatto A, Fontanari C, Galvão AF, Prado MKB, Zoccal KF, Petta T, Moraes LAB de, Ramos SG, Castro FA de, Sorgi CA, Faccioli LH. Erythropoietin exacerbates inflammation and increases the mortality of histoplasma capsulatum-infected mice [Internet]. Mediators of Inflammation. 2015 ; 2015[citado 2024 nov. 16 ] Available from: https://doi.org/10.1155/2015/786319
Vancouver
Locachevic GA, Pereira PAT, Secatto A, Fontanari C, Galvão AF, Prado MKB, Zoccal KF, Petta T, Moraes LAB de, Ramos SG, Castro FA de, Sorgi CA, Faccioli LH. Erythropoietin exacerbates inflammation and increases the mortality of histoplasma capsulatum-infected mice [Internet]. Mediators of Inflammation. 2015 ; 2015[citado 2024 nov. 16 ] Available from: https://doi.org/10.1155/2015/786319
Artigo de periodico-carta/editorial
Pseudomonas aeruginosa carrying blaCTX-M-2 in Brazil [Carta]: the occurrence of ‘high-risk clones’? (2015)
Galetti, Renata; Andrade, Leonardo Neves; Darini, Ana Lúcia da Costa
Source: Journal of Global Antimicrobial Resistance. Unidade: FCFRP
Subjects: PSEUDOMONAS, VIRULÊNCIA, IMUNOLOGIA, EPIDEMIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GALETTI, Renata e ANDRADE, Leonardo Neves e DARINI, Ana Lúcia da Costa. Pseudomonas aeruginosa carrying blaCTX-M-2 in Brazil [Carta]: the occurrence of ‘high-risk clones’?. Journal of Global Antimicrobial Resistance. Amsterdam: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.jgar.2015.04.002. Acesso em: 16 nov. 2024. , 2015
APA
Galetti, R., Andrade, L. N., & Darini, A. L. da C. (2015). Pseudomonas aeruginosa carrying blaCTX-M-2 in Brazil [Carta]: the occurrence of ‘high-risk clones’? Journal of Global Antimicrobial Resistance. Amsterdam: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1016/j.jgar.2015.04.002
NLM
Galetti R, Andrade LN, Darini AL da C. Pseudomonas aeruginosa carrying blaCTX-M-2 in Brazil [Carta]: the occurrence of ‘high-risk clones’? [Internet]. Journal of Global Antimicrobial Resistance. 2015 ; 3 153-154.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jgar.2015.04.002
Vancouver
Galetti R, Andrade LN, Darini AL da C. Pseudomonas aeruginosa carrying blaCTX-M-2 in Brazil [Carta]: the occurrence of ‘high-risk clones’? [Internet]. Journal of Global Antimicrobial Resistance. 2015 ; 3 153-154.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.jgar.2015.04.002
Artigo de periodico
Antibody and cytokine - production during granulomatous response in Schistosoma mansoni - infected mice: role of exposure and treatment with anti-CD28 (2014)
Souza, Laís Cristina de; Dejani, Naiara Naiana; Rodolpho, Joice Margareth de Almeida; Neris, Débora Meira; Oliveira, Sandra Regina Pereira de Oliveira; Correia, Ricardo de Oliveira; Adachi, Felipe Ponte; Faccioli, Lúcia Helena; Rodrigues, Vanderlei; Soares, Edson Garcia; Suazo, Claudio Alberto Torres; Nomizo, Auro; Anibal, Fernanda de Freitas
Source: Elixir Pharmacy. Unidades: FCFRP, FMRP
Subjects: SCHISTOSOMA MANSONI (EXPERIMENTAÇÃO), ANTICORPOS MONOCLONAIS, CITOCINAS, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Laís Cristina de et al. Antibody and cytokine - production during granulomatous response in Schistosoma mansoni - infected mice: role of exposure and treatment with anti-CD28. Elixir Pharmacy, v. 68, p. 22049-22053, 2014Tradução . . Acesso em: 16 nov. 2024.
APA
Souza, L. C. de, Dejani, N. N., Rodolpho, J. M. de A., Neris, D. M., Oliveira, S. R. P. de O., Correia, R. de O., et al. (2014). Antibody and cytokine - production during granulomatous response in Schistosoma mansoni - infected mice: role of exposure and treatment with anti-CD28. Elixir Pharmacy, 68, 22049-22053.
NLM
Souza LC de, Dejani NN, Rodolpho JM de A, Neris DM, Oliveira SRP de O, Correia R de O, Adachi FP, Faccioli LH, Rodrigues V, Soares EG, Suazo CAT, Nomizo A, Anibal F de F. Antibody and cytokine - production during granulomatous response in Schistosoma mansoni - infected mice: role of exposure and treatment with anti-CD28. Elixir Pharmacy. 2014 ; 68 22049-22053.[citado 2024 nov. 16 ]
Vancouver
Souza LC de, Dejani NN, Rodolpho JM de A, Neris DM, Oliveira SRP de O, Correia R de O, Adachi FP, Faccioli LH, Rodrigues V, Soares EG, Suazo CAT, Nomizo A, Anibal F de F. Antibody and cytokine - production during granulomatous response in Schistosoma mansoni - infected mice: role of exposure and treatment with anti-CD28. Elixir Pharmacy. 2014 ; 68 22049-22053.[citado 2024 nov. 16 ]
Artigo de periodico
Influence of Fc'gama'RIIIb polymorphism on its ability to cooperate with Fc'gama'RIIa and CR3 in mediating the oxidative burst of human neutrophils (2014)
Urbaczek, Ana Carolina; Toller-kawahisa, Juliana Escher; Fonseca, Luiz Marcos; Costa, Paulo Inácio; Faria, Carolina Maria Quinello Gomes; Azzolini, Ana Elisa Caleiro Seixas; Lucisano-Valim, Yara Maria; Marzocchi-Machado, Cleni Mara
Source: Human Immunology. Unidade: FCFRP
Subjects: IMUNOLOGIA, POLIMORFISMO, NEUTRÓFILOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
URBACZEK, Ana Carolina et al. Influence of Fc'gama'RIIIb polymorphism on its ability to cooperate with Fc'gama'RIIa and CR3 in mediating the oxidative burst of human neutrophils. Human Immunology, v. 75, n. 8, p. 785-790, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.humimm.2014.05.011. Acesso em: 16 nov. 2024.
APA
Urbaczek, A. C., Toller-kawahisa, J. E., Fonseca, L. M., Costa, P. I., Faria, C. M. Q. G., Azzolini, A. E. C. S., et al. (2014). Influence of Fc'gama'RIIIb polymorphism on its ability to cooperate with Fc'gama'RIIa and CR3 in mediating the oxidative burst of human neutrophils. Human Immunology, 75( 8), 785-790. doi:10.1016/j.humimm.2014.05.011
NLM
Urbaczek AC, Toller-kawahisa JE, Fonseca LM, Costa PI, Faria CMQG, Azzolini AECS, Lucisano-Valim YM, Marzocchi-Machado CM. Influence of Fc'gama'RIIIb polymorphism on its ability to cooperate with Fc'gama'RIIa and CR3 in mediating the oxidative burst of human neutrophils [Internet]. Human Immunology. 2014 ; 75( 8): 785-790.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.humimm.2014.05.011
Vancouver
Urbaczek AC, Toller-kawahisa JE, Fonseca LM, Costa PI, Faria CMQG, Azzolini AECS, Lucisano-Valim YM, Marzocchi-Machado CM. Influence of Fc'gama'RIIIb polymorphism on its ability to cooperate with Fc'gama'RIIa and CR3 in mediating the oxidative burst of human neutrophils [Internet]. Human Immunology. 2014 ; 75( 8): 785-790.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.humimm.2014.05.011

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration